Regulator Expectation for Handling Data Integrity Concerns Draws Spotlight
Jul 30th, 2016
Please Log in to print the full article
Addressing the impact that data integrity concerns are having on FDA and industry at the ISPE/FDA/PQRI Quality Manufacturing Conference in June, Drug Evaluation and Research (CDER) Compliance Officer Acting Director Thomas Cosgrove advised that the...
You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.